Metropolitan Life Insurance Company (MetLife)’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,821	Closed	-$14.7K	–	2373
2023 Q4	$14.7K	Sell	5,821 -2,944	-34%	-$6.86K	﹤0.01%	2043
2023 Q3	$20.9K	Hold	8,765	–	–	﹤0.01%	1873
2023 Q2	$20.2K	Hold	8,765	–	–	﹤0.01%	1922
2023 Q1	$22.4K	Sell	8,765 -650	-7%	-$1.86K	﹤0.01%	1833
2022 Q4	$23.6K	Hold	9,415	–	–	﹤0.01%	1923
2022 Q3	$27.3K	Hold	9,415	–	–	﹤0.01%	1848
2022 Q2	$42.6K	Buy	+9,415	New	+$56K	﹤0.01%	1603

Metropolitan Life Insurance Company (MetLife)'s SLGC Position: Q1 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 5,821 shares — an estimated $14.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SLGC in Q2 2022 and held it in 7 quarters. The position peaked at $42.6K in Q2 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 5,821 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $14.7K.
Metropolitan Life Insurance Company (MetLife) first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
Metropolitan Life Insurance Company (MetLife)'s SomaLogic, Inc. Class A Common Stock position peaked at $42.6K in Q2 2022.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2024, filed 14 May 2024.